Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Pontine Glioma Drug Profiles and Clinical Trials - Global Trends and Analysis Review, H1 2018 -

Research and Markets
Posted on: 28 Feb 18

The "Pontine Glioma Drug Profiles and Clinical Trials- Global Trends and Analysis Review, H1 2018" report has been added to's offering.

Glioma clinical trials report provides comprehensive analysis and trends in global Glioma disease clinical trials. The research work analyzes the evolution of Glioma clinical trial trends across countries and regions.

The report focuses on drugs and therapies being evaluated for Glioma treatment in active clinical development phases including phase 1, phase 2, phase 3 and phase 4 clinical trials. The report also provides trials information by region, key countries, phases, trial status and sponsor types.

Major drugs under development in Glioma are provided in the report along with their details of Mechanism of action, route of administration, target, therapy, molecule and class.

Scope of the Report:

  • Number of Glioma clinical trials across regions - Asia and Oceania, Europe, Middle East Africa and Americas
  • Trial information by Phase and Subjects recruited
  • Trial information by status, type, sponsor type
  • Drugs used for treatment of Glioma
  • Both observational and interventional trials analyzed
  • Success rates of trials are analyzed
  • Trends in enrollment over the past ten years identified
  • Leading sponsors of Glioma clinical trials worldwide are listed

Key Topics Covered:

1 Table of Contents

2 Executive Summary

3 Pontine Glioma Drugs in Ongoing and Completed Trials

4 Global Pontine Glioma Clinical Trial Research Trends

5 Europe Pontine Glioma Clinical Trial Research Trends

6 North America Pontine Glioma Clinical Trial Research Trends

7 Western Pacific Pontine Glioma Clinical Trial Research Trends

8 Recent Clinical Trials - Snapshots

9 Appendix

For more information about this report visit

View source version on

Business Wire

Last updated on: 28/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.